Patents by Inventor Barry Eisenstein

Barry Eisenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7078399
    Abstract: The invention features sulfhydryl rifamycin compositions, methods of making these compositions, and methods for treating disease using these compositions.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: July 18, 2006
    Assignee: ActivBiotics, Inc.
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Barry Eisenstein, William B. Geiss, Joseph Raker
  • Publication number: 20040106590
    Abstract: The invention features methods and compositions including rifalazil for treating Clostridium difficile.
    Type: Application
    Filed: August 29, 2003
    Publication date: June 3, 2004
    Inventor: Barry Eisenstein
  • Publication number: 20040014750
    Abstract: The invention features compositions that include rifamycin analogues formulated with metal salts, metal complexes of rifamycin analogues, and methods for treating disease using these compositions.
    Type: Application
    Filed: December 12, 2002
    Publication date: January 22, 2004
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Barry Eisenstein
  • Publication number: 20040014749
    Abstract: The invention features sulfhydryl rifamycin compositions, methods of making these compositions, and methods for treating disease using these compositions.
    Type: Application
    Filed: December 12, 2002
    Publication date: January 22, 2004
    Inventors: Arthur F. Michaelis, Hawkins V. Maulding, Chalom Sayada, Barry Eisenstein, William B. Geiss, Joseph Raker